Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Feb-24 5:23 PM View:  | Lianbio (LIAN) | 15-Feb-24 | Payment of Exercise | 19,218 | $4.76 | $91,477.70 | (53%) 36.3K to 17.08K | |
| 20-Feb-24 5:23 PM View: | Lianbio (LIAN) | 15-Feb-24 | Option Exercise | 36,300 | $2.52 | $91,476.00 | 100% 0 to 36.3K | |
| 15-Jul-21 5:56 PM View: | Arya Sciences Acquisition C... (ARYE) | 15-Jul-21 | Grant Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K | (< 1%) |
| 02-Mar-21 4:30 PM View: | Arya Sciences Acquisition C... (ARYD) | 02-Mar-21 | Grant Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K | |
| 11-Aug-20 8:43 PM View: | Nautilus Biotechnology, Inc. (NAUT) | 11-Aug-20 | Acquisition (other) Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K | |
| 09-Jun-20 8:25 PM View: | Cerevel Therapeutics Holdin... (CERE) | 09-Jun-20 | Acquisition (other) Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K |